Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

Farnesoid-X receptor (FXR), as a nuclear receptor activated by bile acids, is a vital molecule involved in bile acid metabolism. Due to its expression in immune cells, FXR has a significant effect on the function of immune cells and the release of chemokines when immune cells sense changes in bile a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mengjiao, Wang, Danfeng, Li, Xiang, Cao, Ying, Yi, Chengxue, Wiredu Ocansey, Dickson Kofi, Zhou, Yuling, Mao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583386/
https://www.ncbi.nlm.nih.gov/pubmed/36278234
http://dx.doi.org/10.3389/fphar.2022.1016836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583386/
https://www.ncbi.nlm.nih.gov/pubmed/36278234
http://dx.doi.org/10.3389/fphar.2022.1016836

Ejemplares similares